Phase II Study of Bexarotene in Patients With Acute Myeloid Leukemia
Clinical trial NCT00615784 · TERMINATED
Trial details
- NCT number
- NCT00615784
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-25
- Primary completion
- 2013-10-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.